Although the Covid-19 vaccine is available, Jokowi asks that health protocols continue

JAKARTA, KOMPAS.com – President Joko Widodo called for health protocols to be carried out in a disciplined manner despite Sinovac’s Covid-19 vaccine arriving in Indonesia and landing at Soekarno-Hatta Airport, Tangerang, Banten, on Sunday (12 / 6/2020).

Also read: 1.2 million doses of the Covid-19 vaccine manufactured by Sinovac arrive in Indonesia

“Although vaccines already exist, we still have to be disciplined in carrying out health protocols, maintaining 3M discipline, wearing masks, keeping our distance, washing our hands, we always have to,” Jokowi said in his statement in the YouTube channel of the Presidential Secretariat, on Sunday (6/12/2020). ).

Because, according to him, the vaccination process took a long time. Not to mention, the safety of vaccines must first be verified by the Food and Drug Supervision Agency (BPOM).

In addition, the vaccine is injected into the community in stages for which the plans have been drawn up by the government.

“Because it is not possible to vaccinate all residents simultaneously, I hope that all parties will follow the announcements and instructions of the officials who are currently preparing the vaccines,” said the president.

The 1.2 million doses of the Sinovac vaccine, which arrived Sunday night, are ready to be injected.

Jokowi said 1.8 million more doses of vaccine ready for injection will arrive in January 2021.

Also read: Jokowi: Alhamdulillah, the Covid-19 vaccine is available

In addition, in January 2021, 45 million doses of bulk raw materials will arrive for the manufacture of the Covid-19 vaccine.

The 45 million doses will arrive in two waves. The first wave was 15 million doses and the second wave was 30 million doses.

Meanwhile, Indonesia has collaborated with Sinovac to conduct a third phase clinical trial in Bandung, West Java.

BPOM Director Penny Lukito said that the clinical trial that took place in Bandung was going well.

Also Read: BPOM Calling Sinovac’s Artificial Vaccine Meets Good Drug Production Aspects

In addition to Sinovac, Indonesia has also committed to procuring vaccines with other biopharmaceutical companies such as Sinopharm in collaboration with G42 in the UAE, CanSino and AstraZeneca.